The Only Monthly Membership With a Positive ROI!
España
India
Italia
대한민국
日本
My Account
My Account
Notifications
Overview
+ New Watchlist
Benzinga Research
Benzinga Pro
Log In
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
The Only Monthly Membership With a Positive ROI!
Get Benzinga Pro
Data & APIs
Events
Marketfy
Premarket
Boost
Advertise
Contribute
España
India
Italia
대한민국
日本
Login
Register
Our Services
News
Earnings
Guidance
Dividends
M&A
Buybacks
Legal
Interviews
Management
Offerings
IPOs
Insider Trades
Biotech/FDA
Politics
Government
Healthcare
Markets
Pre-Market
After Hours
Movers
ETFs
Forex
Cannabis
Commodities
Binary Options
Bonds
Futures
CME Group
Global Economics
Mining
Previews
Small-Cap
Real Estate
Cryptocurrency
Penny Stocks
Digital Securities
Volatility
Options
Ratings
Analyst Color
Downgrades
Upgrades
Initiations
Price Target
Ideas
Trade Ideas
Long Ideas
Short Ideas
Technicals
From The Press
Jim Cramer
Rumors
Whisper Index
Stock of the Day
Best Stocks & ETFs
Best Penny Stocks
Best S&P 500 ETFs
Best Swing Trade Stocks
Best Blue Chip Stocks
Best High-Volume Penny Stocks
Best Small Cap ETFs
Best Stocks to Day Trade
Best REITs
Money
Investing
Cryptocurrency
Mortgage
Insurance
Yield
Personal Finance
Forex
Startup Investing
Real Estate Investing
Prop Trading
Credit Cards
Stock Brokers
Crypto
Cannabis
Cannabis Conference
News
Earnings
Interviews
Deals
Regulations
Psychedelics
Jobs
Options
Ratings
Analyst Color
Downgrades
Upgrades
Initiations
Price Target
Ideas
Trade Ideas
Long Ideas
Short Ideas
Technicals
From The Press
Jim Cramer
Rumors
Whisper Index
Stock of the Day
Best Stocks & ETFs
Best Penny Stocks
Best S&P 500 ETFs
Best Swing Trade Stocks
Best Blue Chip Stocks
Best High-Volume Penny Stocks
Best Small Cap ETFs
Best Stocks to Day Trade
Best REITs
Money
Investing
Cryptocurrency
Mortgage
Insurance
Yield
Personal Finance
Forex
Startup Investing
Real Estate Investing
Prop Trading
Credit Cards
Stock Brokers
Crypto
Cannabis
Cannabis Conference
News
Earnings
Interviews
Deals
Regulations
Psychedelics
Jobs
Research
My Stocks
Tools
Free Benzinga Pro Trial
Calendars
Analyst Ratings Calendar
Conference Call Calendar
Dividend Calendar
Earnings Calendar
Economic Calendar
FDA Calendar
Guidance Calendar
IPO Calendar
M&A Calendar
SPAC Calendar
Stock Split Calendar
Trade Ideas
Free Stock Reports
Insider Trades
Trade Idea Feed
Analyst Ratings
Unusual Options Activity
Heatmaps
Free Newsletter
Government Trades
Short Interest
Most Shorted
Largest Increase
Largest Decrease
Calculators
Margin Calculator
Forex Profit Calculator
100x Options Profit Calculator
Recent
Markets
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
Comments
Close menu
Loading...
Teva Pharmaceutical Indus
TEVA
NYSE
Watchlist
Leave a Comment
Logo brought to you by Benzinga Data
Get Report
Perks
Buy
Compare Brokers
Get Report
Perks
Buy
Compare Brokers
$18.56
0.17
0.92%
At Close: -
$18.57
0.01
0.05%
After Hours: 5:03 PM EDT
15 minutes delayed
Get Report
Comment
Teva Pharmaceutical Indus (TEVA) Forecast
News
Earnings
Guidance
Dividends
Analyst Ratings
Insider Trades
Short Interest
Latest news for Teva Pharmaceutical Indus (NYSE:TEVA) Stock
Teva Pharmaceutical Indus Stock (NYSE: TEVA)
Categories: All
All News
General
Contracts
Dividends
Events
FDA
M&A
Offerings
Stock Split
Media
Buybacks
Insider Trades
Earnings
Guidance
Analyst Ratings
Trading Ideas
All News
General
Contracts
Dividends
Events
FDA
M&A
Offerings
Stock Split
Media
Buybacks
Insider Trades
Earnings
Guidance
Analyst Ratings
Trading Ideas
Friday, August 23, 2024
Novo Nordisk's Ozempic Might Be Among 2027 Medicare Price Negotiation Targets
Vandana Singh
Wednesday, August 21, 2024
$1000 Invested In This Stock 5 Years Ago Would Be Worth $2,400 Today
Benzinga Insights
Wednesday, August 14, 2024
Spotlight on Teva Pharmaceutical Indus: Analyzing the Surge in Options Activity
Benzinga Insights
Tuesday, August 13, 2024
$100 Invested In Teva Pharmaceutical Indus 5 Years Ago Would Be Worth This Much Today
Benzinga Insights
Thursday, August 01, 2024
Barclays Maintains Overweight on Teva Pharmac...
Benzinga Newsdesk
Wednesday, July 31, 2024
Tech Stocks On Track For Best Session In 5 Months Ahead Of Fed Meeting; Small Caps Target Highest Close Since January 2022: What's Driving Markets Wednesday?
Piero Cingari
Match Group Posts Upbeat Sales, Joins Modine Manufacturing, Scotts Miracle-Gro, NVIDIA And Other Big Stocks Moving Higher On Wednesday
Avi Kapoor
Teva Beats Q2 Estimates, Raises Annual Outlook On Strong Generic, Austedo Sales
Vandana Singh
Teva Pharmaceuticals Industries shares are tr...
Benzinga Newsdesk
Wall Street Remains On Track For AMD-Led Rebound Ahead Of Fed Decision, Meta Earnings: Analyst Says 'The Bull Tends To Remain' Despite Near-Term Volatility
Shanthi Rexaline
Teva Pharmaceutical Expects 2024 Adjusted EPS...
Benzinga Newsdesk
Teva Pharmaceutical Expects 2024 Revenues Of ...
Benzinga Newsdesk
Teva Pharmaceutical Indus Q2 2024 Adj. EPS $0...
Benzinga Newsdesk
Tuesday, July 30, 2024
10 Health Care Stocks Whale Activity In Today's Session
Benzinga Insights
Monday, July 29, 2024
Hospital Business Recovery to Aid Haemonetics' Q1 Earnings
Zacks
Apple, Amazon, Microsoft, Meta Lead The Charge As Investors Bank On Tech Cheer For Rally's Reacceleration: Week Ahead In Earnings
Shanthi Rexaline
Thursday, July 25, 2024
Teva And Sanofi Fast-Track Anti-TL1A Phase 2b...
Benzinga Newsdesk
Monday, July 22, 2024
Why Hims & Hers Heath Shares Are Surging Today
Vaishali Prayag
Friday, July 19, 2024
$100 Invested In This Stock 5 Years Ago Would Be Worth $200 Today
Benzinga Insights
Thursday, July 18, 2024
Teva's Migraine Treatment Found Effective For Children As Young As 6
Vandana Singh
Teva SPACE Pediatric Phase 3 Study Met Its Pr...
Benzinga Newsdesk
Wednesday, July 17, 2024
Jim Cramer Says Don't Sell Match Group: 'You've Just Got A Very, Very Smart Investor In There'
Avi Kapoor
Tuesday, July 16, 2024
Here's How Much $1000 Invested In Teva Pharmaceutical Indus 5 Years Ago Would Be Worth Today
Benzinga Insights
Monday, July 15, 2024
MediWound Files Amendment To Settlement Agree...
Benzinga Newsdesk
Thursday, July 11, 2024
UBS Maintains Buy on Teva Pharmaceutical Indu...
Benzinga Newsdesk
Monday, July 01, 2024
FTC Crackdown on Teva Pharmaceuticals Over Inhaler Patent Abuse
Vandana Singh
Teva Pharmaceuticals shares are trading lower...
Benzinga Newsdesk
"FTC Opens Investigation Into Teva, Escalatin...
Benzinga Newsdesk
US District Court For The District Of Delawar...
Benzinga Newsdesk
Friday, June 28, 2024
Teva Pharmaceuticals Presents 4th Interim Ana...
Benzinga Newsdesk
Thursday, June 27, 2024
Breaking Down Teva Pharmaceutical Indus: 5 Analysts Share Their Views
Benzinga Insights
Jefferies Maintains Buy on Teva Pharmaceutica...
Benzinga Newsdesk
Tuesday, June 25, 2024
Teva Expects No Impact From Israel Tax Author...
Benzinga Newsdesk
Teva Enters Agreement With Israel Tax Authori...
Benzinga Newsdesk
Monday, June 24, 2024
Teva Pharmaceutical Industries Launches Autho...
Benzinga Newsdesk
Tuesday, June 18, 2024
Teva Engages In Settlement Talks Over Medicare Kickback Allegations
Vandana Singh
Friday, June 14, 2024
Concerpt Therapeutics Shares Are Trading Lower: What You Need To Know
Vaishali Prayag
Reported Late Thursday: Teva Sues Corcept Ove...
Benzinga Newsdesk
Wednesday, June 12, 2024
If You Invested $1000 In This Stock 5 Years Ago, You Would Have $2,100 Today
Benzinga Insights
Tuesday, June 11, 2024
Reported Monday June 10, 2024 "Amneal, U.S. F...
Benzinga Newsdesk
Wednesday, June 05, 2024
Barclays Maintains Overweight on Teva Pharmac...
Benzinga Newsdesk
Sunday, June 02, 2024
Teva Announced Saturday, Switching To UZEDY At Four Weeks After The Last Dose Of Once-monthly Paliperidone Palmitate Provided The Most Comparable Pharmacokinetic Profile Based On The Relevant PK Modeling Data For Schizophrenia
Charles Gross
Thursday, May 30, 2024
4 Analysts Assess Teva Pharmaceutical Indus: What You Need To Know
Benzinga Insights
B of A Securities Maintains Buy on Teva Pharm...
Benzinga Newsdesk
Reported Earlier, Teva's AUSTEDO XR Receives ...
Benzinga Newsdesk
Wednesday, May 22, 2024
Teva Pharmaceutical Indus's Options Frenzy: What You Need to Know
Benzinga Insights
Tuesday, May 21, 2024
Reported Earlier, Teva And Alvotech Announce ...
Benzinga Newsdesk
Saturday, May 18, 2024
Cannabis Meets Prescription Drugs, Steroids And Ketamine In Schedule III: What It Means, Key Stocks To Watch
Nicolás Jose Rodriguez
Monday, May 13, 2024
What the Options Market Tells Us About Teva Pharmaceutical Indus
Benzinga Insights
Piper Sandler Reiterates Overweight on Teva P...
Benzinga Newsdesk
Show More
Create a Watchlist
FREE: Follow your stocks and cryptocurrencies with the most actionable alerts on the internet.
Click to Get Started
People Also Watch